Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 22.25
+2.00 (9.88%)
At close: Apr 2, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 18.02 billion as of April 2, 2026. Its market cap has increased by 73.62% in one year.
Market Cap
18.02B
Enterprise Value
15.91B
Revenue
1.90B
Ranking
n/a
PE Ratio
43.95
Stock Price
22.25
Market Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 18.02B, an increase of 68.75%. That is a compound annual growth rate of 44.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 18.02B | 23.95% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charoen Pokphand Enterprise (Taiwan) | 40.98B |
| Standard Foods | 27.93B |
| Lian Hwa Foods | 27.70B |
| TTET Union | 23.84B |
| Tehmag Foods | 10.36B |
| Microbio | 10.15B |
| Taisun Enterprise | 9.46B |
| Ve Wong | 9.37B |